IMP
Process View
cellular glucose homeostasis
A cellular homeostatic process involved in the maintenance of an internal steady state of glucose within a cell or between a cell and its external environment.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cellular glucose homeostasis"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.565 | ||
| MAFA | v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) | 0.293 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.232 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.232 | Rat | |
| PLAU | plasminogen activator, urokinase | 0.215 | Rat | |
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.206 | ||
| CCNY | cyclin Y | 0.198 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.184 | Rat | |
| INCENP | inner centromere protein antigens 135/155kDa | 0.164 | ||
| MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.137 | ||
| SMAD3 | SMAD family member 3 | 0.120 | ||
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.112 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.108 | Human | |
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.104 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.070 | ||
| AXL | AXL receptor tyrosine kinase | 0.070 | ||
| NAPA | N-ethylmaleimide-sensitive factor attachment protein, alpha | 0.063 | ||
| RANBP9 | RAN binding protein 9 | 0.063 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.058 | ||
| NR2E3 | nuclear receptor subfamily 2, group E, member 3 | 0.055 | ||
| NME1 | non-metastatic cells 1, protein (NM23A) expressed in | 0.050 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.047 | ||
| CRHR1 | corticotropin releasing hormone receptor 1 | 0.046 | ||
| S100B | S100 calcium binding protein B | 0.044 | ||
| NME2 | non-metastatic cells 2, protein (NM23B) expressed in | 0.041 | Rat | |
| SNAP25 | synaptosomal-associated protein, 25kDa | 0.037 | ||
| SMAD2 | SMAD family member 2 | 0.037 | ||
| IRF2 | interferon regulatory factor 2 | 0.037 | ||
| PLAT | plasminogen activator, tissue | 0.036 | ||
| SNAP23 | synaptosomal-associated protein, 23kDa | 0.036 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.034 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.033 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.033 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.032 | ||
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.032 | ||
| RYR2 | ryanodine receptor 2 (cardiac) | 0.030 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.030 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.028 | ||
| AKAP11 | A kinase (PRKA) anchor protein 11 | 0.026 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.025 | ||
| ATN1 | atrophin 1 | 0.025 | ||
| RNASE4 | ribonuclease, RNase A family, 4 | 0.024 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.023 | ||
| MKL1 | megakaryoblastic leukemia (translocation) 1 | 0.022 | ||
| MPDZ | multiple PDZ domain protein | 0.022 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.022 | ||
| PPP2R1A | protein phosphatase 2, regulatory subunit A, alpha | 0.022 | ||
| IL1B | interleukin 1, beta | 0.021 | Rat | |
| CREBBP | CREB binding protein | 0.021 | ||
| DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.021 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.020 | ||
| MGEA5 | meningioma expressed antigen 5 (hyaluronidase) | 0.019 | ||
| MYOCD | myocardin | 0.019 | ||
| PXN | paxillin | 0.018 | ||
| NME3 | non-metastatic cells 3, protein expressed in | 0.018 | ||
| PPP2CB | protein phosphatase 2, catalytic subunit, beta isozyme | 0.018 | ||
| HDAC3 | histone deacetylase 3 | 0.017 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.017 | ||
| ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | 0.016 | ||
| DAXX | death-domain associated protein | 0.016 | ||
| MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) | 0.016 | ||
| HDAC1 | histone deacetylase 1 | 0.015 | ||
| IPO13 | importin 13 | 0.015 | ||
| SHMT2 | serine hydroxymethyltransferase 2 (mitochondrial) | 0.015 | ||
| VIM | vimentin | 0.013 | ||
| NME4 | non-metastatic cells 4, protein expressed in | 0.013 | ||
| ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | 0.013 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.013 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.013 | ||
| GABARAPL1 | GABA(A) receptor-associated protein like 1 | 0.012 | ||
| TRAF6 | TNF receptor-associated factor 6 | 0.012 | ||
| PPP3R1 | protein phosphatase 3, regulatory subunit B, alpha | 0.012 | ||
| EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 | 0.012 | ||
| MYO16 | myosin XVI | 0.012 | ||
| CARS | cysteinyl-tRNA synthetase | 0.012 | ||
| PPP2R2C | protein phosphatase 2, regulatory subunit B, gamma | 0.012 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.012 | ||
| YY1 | YY1 transcription factor | 0.012 | ||
| ARRB2 | arrestin, beta 2 | 0.011 | ||
| MAPK10 | mitogen-activated protein kinase 10 | 0.011 | ||
| ULK1 | unc-51-like kinase 1 (C. elegans) | 0.011 | ||
| HMGA1 | high mobility group AT-hook 1 | 0.011 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.010 | ||
| HCFC1 | host cell factor C1 (VP16-accessory protein) | 0.010 | ||
| LMNA | lamin A/C | 0.010 | ||
| PRDX1 | peroxiredoxin 1 | 0.010 | ||
| GJA1 | gap junction protein, alpha 1, 43kDa | 0.010 | ||
| HIC1 | hypermethylated in cancer 1 | 0.010 |